Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $47,690 | 24 | 74.3% |
| Travel and Lodging | $13,738 | 29 | 21.4% |
| Food and Beverage | $2,744 | 41 | 4.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Genentech USA, Inc. | $40,785 | 41 | $0 (2020) |
| AstraZeneca Pharmaceuticals LP | $12,398 | 22 | $0 (2024) |
| Alexion Pharmaceuticals, Inc. | $10,877 | 24 | $0 (2022) |
| Janssen Pharmaceuticals, Inc | $29.38 | 2 | $0 (2020) |
| PORTOLA PHARMACEUTICALS, LLC | $29.09 | 2 | $0 (2020) |
| E.R. Squibb & Sons, L.L.C. | $23.21 | 1 | $0 (2020) |
| ABBVIE INC. | $18.81 | 1 | $0 (2023) |
| PFIZER INC. | $11.15 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $300.00 | 1 | AstraZeneca Pharmaceuticals LP ($300.00) |
| 2023 | $4,433 | 14 | AstraZeneca Pharmaceuticals LP ($4,414) |
| 2022 | $8,682 | 11 | AstraZeneca Pharmaceuticals LP ($7,684) |
| 2021 | $9,880 | 21 | Alexion Pharmaceuticals, Inc. ($9,880) |
| 2020 | $106.74 | 6 | Genentech USA, Inc. ($37.58) |
| 2019 | $40,757 | 40 | Genentech USA, Inc. ($40,733) |
| 2017 | $14.62 | 1 | Genentech USA, Inc. ($14.62) |
All Payment Transactions
94 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/13/2024 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $300.00 | General |
| Category: Rare Disease | ||||||
| 11/16/2023 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $300.00 | General |
| Category: Rare Disease | ||||||
| 10/12/2023 | ABBVIE INC. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $18.81 | General |
| Category: ANTI-INFECTIVE | ||||||
| 06/01/2023 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,750.00 | General |
| Category: Rare Disease | ||||||
| 05/05/2023 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Travel and Lodging | In-kind items and services | $86.33 | General |
| Category: Rare Disease | ||||||
| 05/05/2023 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Food and Beverage | In-kind items and services | $57.60 | General |
| Category: Rare Disease | ||||||
| 05/05/2023 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Food and Beverage | In-kind items and services | $18.00 | General |
| Category: Rare Disease | ||||||
| 05/04/2023 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Travel and Lodging | In-kind items and services | $407.36 | General |
| Category: Rare Disease | ||||||
| 05/04/2023 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Travel and Lodging | In-kind items and services | $347.58 | General |
| Category: Rare Disease | ||||||
| 05/04/2023 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Travel and Lodging | In-kind items and services | $209.00 | General |
| Category: Rare Disease | ||||||
| 05/04/2023 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Food and Beverage | In-kind items and services | $129.40 | General |
| Category: Rare Disease | ||||||
| 05/04/2023 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Food and Beverage | In-kind items and services | $28.80 | General |
| Category: Rare Disease | ||||||
| 05/04/2023 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Food and Beverage | In-kind items and services | $16.20 | General |
| Category: Rare Disease | ||||||
| 05/04/2023 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Food and Beverage | In-kind items and services | $14.40 | General |
| Category: Rare Disease | ||||||
| 03/27/2023 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Food and Beverage | In-kind items and services | $49.37 | General |
| Category: Rare Disease | ||||||
| 11/01/2022 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,700.00 | General |
| Category: Rare Disease | ||||||
| 10/25/2022 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: Rare Disease | ||||||
| 10/25/2022 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Travel and Lodging | In-kind items and services | $117.50 | General |
| Category: Rare Disease | ||||||
| 10/02/2022 | Alexion Pharmaceuticals, Inc. | ANDEXXA (Biological) | Food and Beverage | In-kind items and services | $32.86 | General |
| Category: Rare Disease | ||||||
| 09/13/2022 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,700.00 | General |
| Category: Rare Disease | ||||||
| 09/08/2022 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Travel and Lodging | In-kind items and services | $1,016.82 | General |
| Category: Rare Disease | ||||||
| 09/08/2022 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: Rare Disease | ||||||
| 05/13/2022 | Alexion Pharmaceuticals, Inc. | ANDEXXA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $915.00 | General |
| Category: Rare Disease | ||||||
| 05/10/2022 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $450.00 | General |
| Category: Rare Disease | ||||||
| 02/20/2022 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $450.00 | General |
| Category: Rare Disease | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 454 | 472 | $566,589 | $57,610 |
| 2022 | 5 | 439 | 446 | $500,386 | $57,271 |
| 2021 | 4 | 414 | 422 | $517,296 | $61,113 |
| 2020 | 4 | 418 | 422 | $522,199 | $59,773 |
All Medicare Procedures & Services
18 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99285 | Emergency department visit with high level of medical decision making | Facility | 2023 | 242 | 256 | $363,015 | $37,151 | 10.2% |
| 99284 | Emergency department visit with moderate level of medical decision making | Facility | 2023 | 150 | 154 | $147,506 | $15,434 | 10.5% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 22 | 22 | $39,919 | $3,607 | 9.0% |
| 99283 | Emergency department visit with low level of medical decision making | Facility | 2023 | 25 | 25 | $14,799 | $1,314 | 8.9% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 15 | 15 | $1,350 | $103.80 | 7.7% |
| 99285 | Emergency department visit for life threatening or functioning severity | Facility | 2022 | 278 | 280 | $388,464 | $44,887 | 11.6% |
| 99284 | Emergency department visit for problem of high severity | Facility | 2022 | 56 | 57 | $53,053 | $6,094 | 11.5% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 17 | 19 | $34,138 | $3,785 | 11.1% |
| 99283 | Emergency department visit for problem of moderate severity | Facility | 2022 | 34 | 34 | $19,691 | $2,106 | 10.7% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2022 | 54 | 56 | $5,040 | $399.14 | 7.9% |
| 99285 | Emergency department visit, problem with significant threat to life or function | Facility | 2021 | 296 | 304 | $409,139 | $48,310 | 11.8% |
| 99284 | Emergency department visit, problem of high severity | Facility | 2021 | 65 | 65 | $59,120 | $7,016 | 11.9% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 18 | 18 | $30,658 | $3,597 | 11.7% |
| 99283 | Emergency department visit, moderately severe problem | Facility | 2021 | 35 | 35 | $18,379 | $2,191 | 11.9% |
| 99285 | Emergency department visit, problem with significant threat to life or function | Facility | 2020 | 292 | 296 | $393,818 | $45,850 | 11.6% |
| 99284 | Emergency department visit, problem of high severity | Facility | 2020 | 73 | 73 | $68,175 | $7,290 | 10.7% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2020 | 26 | 26 | $43,661 | $5,201 | 11.9% |
| 99283 | Emergency department visit, moderately severe problem | Facility | 2020 | 27 | 27 | $16,545 | $1,431 | 8.7% |
About Dr. Leroy Nickles, M.D
Dr. Leroy Nickles, M.D is a Emergency Medicine healthcare provider based in New York, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/02/2006. The National Provider Identifier (NPI) number assigned to this provider is 1710070412.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Leroy Nickles, M.D has received a total of $64,172 in payments from pharmaceutical and medical device companies, with $300.00 received in 2024. These payments were reported across 94 transactions from 8 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($47,690).
As a Medicare-enrolled provider, Nickles has provided services to 1,725 Medicare beneficiaries, totaling 1,762 services with total Medicare billing of $235,767. Data is available for 4 years (2020–2023), covering 18 distinct procedure/service records.
Practice Information
- Specialty Emergency Medicine
- Other Specialties Emergency Medicine, Emergency Medicine
- Location New York, NY
- Active Since 10/02/2006
- Last Updated 03/21/2024
- Taxonomy Code 207P00000X
- Entity Type Individual
- NPI Number 1710070412
Products in Payments
- Activase (Biological) $20,815
- ANDEXXA (Biological) $13,425
- Andexxa (Drug) $9,880
- ELIQUIS (Drug) $34.36
- XARELTO (Drug) $29.38
- DALVANCE (Drug) $18.81
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Emergency Medicine Doctors in New York
Benjamin Abella, Md, MD
Emergency Medicine — Payments: $187,938
Dr. Sohan Parekh, M.d, M.D
Emergency Medicine — Payments: $156,713
Jonathan Schimmel, Md, MD
Emergency Medicine — Payments: $85,352
Bret Nelson, Md, MD
Emergency Medicine — Payments: $63,058
Yves Duroseau, Md, MD
Emergency Medicine — Payments: $46,664
Jeffrey Goldstein, D.o, D.O
Emergency Medicine — Payments: $26,302